Article Text

Download PDFPDF
Role of linoleic acid in autoimmune disorders: a Mendelian randomisation study
  1. Jie V Zhao1,
  2. C Mary Schooling1,2
  1. 1 School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
  2. 2 School of Public Health and Health Policy, City University of New York, New York, NY, USA
  1. Correspondence to Dr Jie V Zhao, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; janezhao410{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Autoimmune diseases are a major challenge for global health. From an evolutionary biology perspective, reproduction, particularly androgens, trades off against immune activity.1 Correspondingly, trials suggest androgens improve rheumatoid arthritis (RA).2 3 As such, dietary factors promoting reproduction might prevent or treat autoimmune disorders. Linoleic acid (LA) is a major n−6 polyunsaturated fatty acid (PUFA) in widely used polyunsaturated vegetable oils, such as sunflower, corn, soybean and cottonseed oil. In animal experiments, LA stimulates the synthesis of testosterone.4 Observationally, endogenous LA is inversely associated with RA5 and systemic lupus erythematosus (SLE),6 but these findings have not been confirmed in randomised controlled trials. Comparing autoimmune disorders according to naturally occurring LA-related genetic variants, that is, Mendelian randomisation (MR), provides a means of obtaining unconfounded estimates of causal effects.

We obtained strong, independent genetic predictors of LA using (1) the three most significant uncorrelated single-nucleotide polymorphisms (SNPs) and (2) …

View Full Text


  • Handling editor Josef S Smolen

  • Contributors JVZ and CMS designed the study. JVZ analysed data and interpreted the results with the help of CMS. JVZ drafted the paper. CMS critically revised the paper. All authors read and approved the final manuscript.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.